These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The effects of periodontal therapy on gingival crevicular fluid matrix metalloproteinase-8, interleukin-6 and prostaglandin E2 levels in patients with rheumatoid arthritis. Kurgan Ş; Fentoğlu Ö; Önder C; Serdar M; Eser F; Tatakis DN; Günhan M J Periodontal Res; 2016 Oct; 51(5):586-95. PubMed ID: 26575440 [TBL] [Abstract][Full Text] [Related]
12. Assessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis. Kobayashi T; Okada M; Ito S; Kobayashi D; Ishida K; Kojima A; Narita I; Murasawa A; Yoshie H J Periodontol; 2014 Jan; 85(1):57-67. PubMed ID: 23489234 [TBL] [Abstract][Full Text] [Related]
13. Periodontal inflammation and distinct inflammatory profiles in saliva and gingival crevicular fluid compared with serum and joints in rheumatoid arthritis patients. Arvikar SL; Hasturk H; Strle K; Stephens D; Bolster MB; Collier DS; Kantarci A; Steere AC J Periodontol; 2021 Oct; 92(10):1379-1391. PubMed ID: 33611834 [TBL] [Abstract][Full Text] [Related]
14. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults. Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644 [TBL] [Abstract][Full Text] [Related]
15. Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. Gursoy UK; Könönen E; Pradhan-Palikhe P; Tervahartiala T; Pussinen PJ; Suominen-Taipale L; Sorsa T J Clin Periodontol; 2010 Jun; 37(6):487-93. PubMed ID: 20507371 [TBL] [Abstract][Full Text] [Related]
16. Assessment of aprotinin influence on periodontal clinical status and matrix metalloproteinases 1, 2 and their tissue inhibitors saliva concentrations in patients with chronic periodontitis. Pietruska M; Pietruski J; Skurska A; Bernaczyk A; Zak J; Zelazowska B; Dolińska E; Paniczko-Drezek A; Wysocka J Adv Med Sci; 2009; 54(2):239-46. PubMed ID: 19758971 [TBL] [Abstract][Full Text] [Related]
17. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954 [TBL] [Abstract][Full Text] [Related]
18. [Expression of matrix metalloproteinase-3 in patients with reheumatoid arthritis and its correlation with chronic periodontitis and rheumatoid arthritis]. Zhao Y; Jin Y; Ren YS; Song LM; Li J; Lin XP Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Mar; 54(3):164-169. PubMed ID: 30856693 [No Abstract] [Full Text] [Related]
19. Salivary and serum procalcitonin and C-reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthritis. Redman RS; Kerr GS; Payne JB; Mikuls TR; Huang J; Sayles HR; Becker KL; Nylén ES Biotech Histochem; 2016; 91(2):77-85. PubMed ID: 26800284 [TBL] [Abstract][Full Text] [Related]
20. The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity. Toubi E; Kessel A; Grushko G; Sabo E; Rozenbaum M; Rosner I Clin Exp Rheumatol; 2002; 20(2):221-4. PubMed ID: 12051403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]